Avant Diagnostics, Inc Forms 3, 4 and 5: Other
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 3 rows, 3 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2017-06-28: Reporting owner Vandermeer Scott; Form 3; Security Common Stock Purchase Rights; Transaction Holding.
- 2017-06-28: Reporting owner INFUSION 51A, L.P.; Form 3; Security Common Stock Purchase Rights; Transaction Holding.
- 2017-06-28: Reporting owner Stephens Jeffrey; Form 3; Security Common Stock Purchase Rights; Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2017-06-28 holding as of filing | Vandermeer Scott 10% Owner | 3 | Common Stock Purchase Rights Derivative · Indirect · Through Infusion 51a, LP | Holding | $0.06 exercise price | 2017-06-28 | ||
| 2017-06-28 holding as of filing | INFUSION 51A, L.P. 10% Owner | 3 | Common Stock Purchase Rights Derivative · Direct | Holding | $0.06 exercise price | 2017-06-28 | ||
| 2017-06-28 holding as of filing | Stephens Jeffrey Director, 10% Owner | 3 | Common Stock Purchase Rights Derivative · Indirect · Through Infusion 51a, LP | Holding | $0.06 exercise price | 2017-06-28 |